Cost-effectiveness of interferon treatment for chronic hepatitis C.

被引：0
|
作者：
Kareemi, M
Peltekian, KM
机构：
[1] QUEEN ELIZABETH II HLTH SCI CTR,DEPT MED,HALIFAX,NS,CANADA
[2] DALHOUSIE UNIV,HALIFAX,NS,CANADA
来源：
HEPATOLOGY | 1996年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：597 / 597
页数：1
相关论文
共 50 条
  • [41] New Protease Inhibitors for the Treatment of Chronic Hepatitis C A Cost-Effectiveness Analysis
    Liu, Shan
    Cipriano, Lauren E.
    Holodniy, Mark
    Owens, Douglas K.
    Goldhaber-Fiebert, Jeremy D.
    [J]. ANNALS OF INTERNAL MEDICINE, 2012, 156 (04) : 279 - U68
  • [42] Cost-effectiveness of sofosbuvir for the treatment of chronic hepatitis C infected patients in the UK
    Cure, Sandrine
    Guerra, Ines
    Dusheiko, Geoffrey M.
    [J]. HEPATOLOGY, 2014, 60 : 660A - 660A
  • [43] Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population
    Salomon, JA
    Weinstein, MC
    Hammitt, JK
    Goldie, SJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02): : 228 - 237
  • [44] COST-EFFECTIVENESS OF BOCEPREVIR IN THE TREATMENT OF CHRONIC HEPATITIS C GENOTYPE 1 IN SWEDEN
    Chhatwal, J.
    Lundberg, J.
    Ferrante, S.
    El Khourhy, A. C.
    Oksanen, A.
    Elbasha, E. H.
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 : S386 - S387
  • [45] Cost-effectiveness analysis of interferon α-2b with ribavirin for chronic hepatitis C infection
    Malone, DC
    [J]. FORMULARY, 2000, 35 (08) : 681 - +
  • [46] Cost-effectiveness analysis of therapeutic strategies for patients with chronic hepatitis C previously not responding to interferon
    San Miguel, R
    Mar, J
    Cabasés, JM
    Guillén-Grima, F
    Buti, M
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (06) : 765 - 773
  • [47] Cost-effectiveness of initial ribavirin interferon alfa-2B for chronic hepatitis C
    Wong, J
    McHutchinson, JG
    Poynard, T
    Ling, MH
    Albrecht, HK
    Pauker, SD
    [J]. GASTROENTEROLOGY, 1999, 116 (04) : A1289 - A1289
  • [48] Cost-effectiveness of 6 and 12 months of interferon-alpha therapy for chronic hepatitis C
    Kim, WR
    Poterucha, JJ
    Hermans, JE
    Therneau, TM
    Dickson, ER
    Evans, RW
    Gross, JB
    [J]. ANNALS OF INTERNAL MEDICINE, 1997, 127 (10) : 866 - +
  • [49] Clinical- and cost-effectiveness of pegylated interferon alfa in the treatment of chronic hepatitis C: A systematic review and economic evaluation
    Shepherd, J
    Brodin, HFT
    Cave, CB
    Waugh, NR
    Price, A
    Gabbay, J
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2005, 21 (01) : 47 - 54
  • [50] Cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C - Reply
    Myers, RP
    Gregor, JC
    Marotta, PJ
    [J]. HEPATOLOGY, 2000, 32 (04) : 874 - 875
12345